
Anti-tuberculosis lupane-type isoprenoids from Syzygium guineense Wild DC. (Myrtaceae) stem bark
Author(s) -
I. A. Oladosu,
Lovett Lawson,
Olapeju O. Aiyelaagbe,
Nnamdi Emenyonu,
Ozadheoghene Eriarie Afieroho
Publication year - 2017
Publication title -
future journal of pharmaceutical sciences
Language(s) - English
Resource type - Journals
eISSN - 2314-7253
pISSN - 2314-7245
DOI - 10.1016/j.fjps.2017.05.002
Subject(s) - betulinic acid , terpenoid , traditional medicine , mycobacterium tuberculosis , chemistry , bark (sound) , terpene , tuberculosis , biology , stereochemistry , medicine , ecology , genetics , pathology
Plant derived isoprenoids commonly called terpenoids, are not only useful as chemosytemic markers but are increasingly attracting attention in the development of newer drugs for the treatment of multi-drug resistant tuberculosis. Anti-tuberculosis activity guided solvent fractionation and chromatographic separation of the chloroform extract of S. guineense stem bark resulted in the isolation of two bioactive 3-β-hydroxylupane-type isoprenoids: betulinic acid methylenediol ester (1) (MIC; 0.15 mg/mL) and betulinic acid (2) (MIC; 0.60 mg/mL). The structures of the isolated compounds were elucidated using spectroscopic techniques. The antituberculosis assay was done using the Mycobacterium Growth Indicator Tube (MGIT) method. This is the first report of the isolation of the anti-tuberculosis constituents of S. guineense and its potentials for the development of drug leads for the treatment of tuberculosis thus validating its ethno-medicinal uses